ATE77557T1 - Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. - Google Patents

Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.

Info

Publication number
ATE77557T1
ATE77557T1 AT88309826T AT88309826T ATE77557T1 AT E77557 T1 ATE77557 T1 AT E77557T1 AT 88309826 T AT88309826 T AT 88309826T AT 88309826 T AT88309826 T AT 88309826T AT E77557 T1 ATE77557 T1 AT E77557T1
Authority
AT
Austria
Prior art keywords
increase
levels
composition
rate
physical performance
Prior art date
Application number
AT88309826T
Other languages
English (en)
Inventor
Francis J Carniglia
Original Assignee
Roncari Raymond A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roncari Raymond A filed Critical Roncari Raymond A
Application granted granted Critical
Publication of ATE77557T1 publication Critical patent/ATE77557T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
AT88309826T 1987-12-29 1988-10-19 Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. ATE77557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/139,288 US4871718A (en) 1987-12-29 1987-12-29 Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
EP88309826A EP0324227B1 (de) 1987-12-29 1988-10-19 Zusammensetzung zur Erhöhung der Intrazell-ATP-Spiegel und des physischen Leistungsniveaus und zur Erhöhung der Geschwindigkeit von Wundenheilung

Publications (1)

Publication Number Publication Date
ATE77557T1 true ATE77557T1 (de) 1992-07-15

Family

ID=22485942

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88309826T ATE77557T1 (de) 1987-12-29 1988-10-19 Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.

Country Status (12)

Country Link
US (2) US4871718A (de)
EP (1) EP0324227B1 (de)
JP (1) JPH01175939A (de)
AT (1) ATE77557T1 (de)
AU (1) AU600139B2 (de)
CA (1) CA1325593C (de)
DE (2) DE324227T1 (de)
DK (1) DK726088A (de)
ES (1) ES2045141T3 (de)
GR (1) GR900300016T1 (de)
IE (1) IE62263B1 (de)
NZ (1) NZ225106A (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
IT1247125B (it) * 1991-03-01 1994-12-12 Depha Team Srl Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
US5195940A (en) * 1991-06-20 1993-03-23 Iatromed, Inc. Method for increased production of growth factor in living tissue using an applied fluctuating magnetic field
AP387A (en) * 1991-09-13 1995-07-31 Siegbert Heinrich Bissbort Therapeutical uses of L-methionine and compositions thereof.
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
AU4151996A (en) * 1994-11-08 1996-05-31 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system
AU4704596A (en) * 1995-01-20 1996-08-07 Francis J. Carniglia Diet compositions to treat ascites in domestic animals
WO1996033703A2 (en) * 1995-04-25 1996-10-31 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US5827874A (en) * 1995-05-05 1998-10-27 Meyer; Hans Methods of treating pain and inflammation with proline
US5571518A (en) * 1995-10-30 1996-11-05 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing tricholine citrate
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US8128955B2 (en) * 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6218366B1 (en) * 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
GB9814039D0 (en) * 1998-06-29 1998-08-26 Univ London Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
FR2782270B1 (fr) * 1998-08-12 2001-06-22 Michel Seman Adenosine et nucleotides adenyliques par voie orale pour l'amelioration du travail musculaire
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
AU7828200A (en) 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
WO2001032168A1 (en) 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
AU2770601A (en) 2000-01-07 2001-07-24 Bioenergy Inc. Compositions for enhancing the immune response
KR100338491B1 (ko) * 2000-03-30 2002-05-30 채수경 인중합체로 된 흉터 억제 및 상처 회복 촉진제
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US6553254B1 (en) * 2000-04-07 2003-04-22 Keith E. Kenyon Combination of non-living-source physical energy and living-source chemical energy to maximize the salvage of ATP
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
DE60125191T2 (de) * 2000-07-28 2007-10-25 Bioenergy Inc., Ham Lake Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion
JP2002338473A (ja) * 2001-05-15 2002-11-27 Yaizu Suisankagaku Industry Co Ltd 抗疲労組成物
US6855727B2 (en) 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20040147458A1 (en) * 2002-03-28 2004-07-29 Van Tassel Richard K Compositions to reduce exercise-induced swelling of joints
US20040127428A1 (en) * 2002-12-28 2004-07-01 Kenyon Keith E. Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures
US7494643B2 (en) * 2003-07-22 2009-02-24 Rendon Marta I Method and topical composition for the treatment of hyperpigmented skin
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
WO2005032278A1 (en) 2003-09-29 2005-04-14 Soft Gel Technologies, Inc. SOLUBILIZED CoQ-10
CA2556967A1 (en) * 2004-02-23 2005-09-09 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
EP1734974A1 (de) * 2004-03-18 2006-12-27 Tanabe Seiyaku Co., Ltd. D-ribose zur verbesserung von depressionsartigen symptomen
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
EP3508201A3 (de) * 2004-08-09 2019-10-16 Enrique Melendez Hevia Glycin als dietätische zugabe zur verwendung in der behandlung von hautproblemen, die aus zugrundeliegenden kollagenstörungen resultieren
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US20050249803A1 (en) * 2005-06-03 2005-11-10 Udell Ronald G Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
JP5220415B2 (ja) * 2005-09-06 2013-06-26 株式会社明治 老人性貧血を防止又は治療するためのアミノ酸組成物
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US7989009B2 (en) * 2006-02-02 2011-08-02 Advocare International, L.P. Composition and method for promoting weight loss
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
US7745486B2 (en) * 2006-07-17 2010-06-29 Quercegen Pharma Llc Quercetin-containing compositions
WO2008011364A2 (en) * 2006-07-17 2008-01-24 Thomas Christian Lines Quercetin-containing compositions
EP1970761B1 (de) * 2007-03-14 2012-02-29 FUJIFILM Corporation Lichtempfindliche Zusammensetzung und Herstellungsverfahren für ein gehärtetes Reliefmuster
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
US20090061016A1 (en) * 2007-09-05 2009-03-05 Selzer Jonathan A Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement
JP5235439B2 (ja) * 2008-02-06 2013-07-10 丸善製薬株式会社 ＨＭＧ−ＣｏＡ還元酵素産生促進剤
US20090005320A1 (en) * 2008-09-02 2009-01-01 Bruce Kneller Compositions comprising amino acid bicarbonate and methods of use thereof
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
RU2505291C2 (ru) 2009-06-24 2014-01-27 СТРАТЕДЖИК САЙЕНС ЭНД ТЕКНОЛОДЖИЗ, ЭлЭлСи Топическая композиция, содержащая ибупрофен
WO2011103179A1 (en) * 2010-02-16 2011-08-25 Viacell, Llc Arginine-containing compositions and methods for treating red blood cells
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
ES2811515T3 (es) 2010-12-29 2021-03-12 Strategic Science & Tech Llc Tratamiento de disfunción eréctil y otras indicaciones
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
EP2859889A1 (de) * 2013-10-14 2015-04-15 Abbott Laboratories Zusammensetzungen und Verfahren zur Verbesserung der kognitiven Funktion
WO2017136143A1 (en) 2016-02-01 2017-08-10 Ribocor, Inc. Use of ribose for treatment of subjects having congestive heart failure
WO2018089954A1 (en) 2016-11-10 2018-05-17 BioRegentech Laser assisted wound healing protocol and system
US11654293B2 (en) * 2016-11-10 2023-05-23 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
US20210100347A1 (en) * 2018-01-25 2021-04-08 Se In Oh Toothbrush comprising bristles having different lengths
EP3886838A4 (de) 2018-11-30 2022-08-10 Beth Israel Deaconess Medical Center, Inc. Zusammensetzungen und verfahren zur verminderung von schweren thrombotischen ereignissen bei krebspatienten
JPWO2023135827A1 (de) * 2022-01-13 2023-07-20

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2417841A (en) * 1944-06-21 1947-03-25 Frances R Ruskin Nucleotide compounds of components of vitamin b complex
US2844514A (en) * 1953-11-04 1958-07-22 Pabst Brewing Co Process for the production of nucleotides
US3009859A (en) * 1958-07-22 1961-11-21 Laborit Henri Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions
US3104203A (en) * 1959-12-09 1963-09-17 Union Carbide Corp Composition of matter containing procaine adenylate
US3157635A (en) * 1960-08-05 1964-11-17 Takeda Chemical Industries Ltd Sulfonic acid cation exchange resin purification of nucleotides
DE1442304A1 (de) * 1962-08-08 1970-01-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Purinderivaten
US3329567A (en) * 1963-09-16 1967-07-04 Union Carbide Corp Synergistic effect of adenylic nucleotides in digitalis therapy
DE1692496A1 (de) * 1965-01-27 1971-08-05 Takeda Chemical Industries Ltd Futtermittel
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
US3819830A (en) * 1971-07-01 1974-06-25 Dainippon Pharmaceutical Co Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
US3978213A (en) * 1972-07-10 1976-08-31 Nelson Research & Development Company Cosmetic use of cyclic amp and phosphodiesterase inhibitors
ZA7468B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
US4211770A (en) * 1973-01-16 1980-07-08 The Upjohn Company Treatment of psoriasis intralesionally with N6 -2'-O-dibutyryl cyclic AMP
US3988466A (en) * 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
DE2509531A1 (de) * 1975-03-05 1976-09-16 Thomae Gmbh Dr K Antivirales mittel
US4363818A (en) * 1975-06-04 1982-12-14 Gottlieb Sheldon K Method for relief of burning, itching, and pain of cutaneous and mucosal surfaces
US4126701A (en) * 1975-10-24 1978-11-21 A.H.P., Inc. Process of sparing poultry from the effect of toxins
US4078971A (en) * 1976-03-31 1978-03-14 Temple University Bound, active cellular organelles and method of producing same
US4207315A (en) * 1976-10-20 1980-06-10 University Patents, Inc. Process for treating proliferative skin diseases using certain diamino compounds
US4414202A (en) * 1980-02-19 1983-11-08 Silvetti Anthony N Composition for treatment of wounds
US4308257A (en) * 1980-06-03 1981-12-29 Saul Caspe Accelerating cellular repair composition for the human body and method of administering same
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4546095A (en) * 1980-07-21 1985-10-08 Markov Angel K Use of fructose-1,6-diphosphate for treating myocardial infarction
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
US4362745A (en) * 1980-11-19 1982-12-07 Johnston Frederick B Medical process and preparation
EP0076841A4 (de) * 1981-04-17 1984-01-16 American Hospital Supply Corp Verbesserte lösung für parenterale nährung.
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
JPS58129970A (ja) * 1982-01-26 1983-08-03 Kazutomo Imahori アデノシン三リン酸変換用装置
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
EP0150053B1 (de) * 1984-01-18 1990-06-13 Oehmke, Martin, Dr. Niedrig osmotisches hypokalorisches wässriges Präparat für die Infusion
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
ES2038122T3 (es) * 1985-11-18 1993-07-16 Beecham Group Plc Un procedimiento para la preparacion de una composicion veterinaria2.
US4923851A (en) * 1987-12-29 1990-05-08 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4983394A (en) * 1990-05-03 1991-01-08 Warner-Lambert Company Flavor enhancing and medicinal taste masking agent

Also Published As

Publication number Publication date
JPH01175939A (ja) 1989-07-12
IE62263B1 (en) 1995-01-11
IE882583L (en) 1989-06-29
EP0324227A1 (de) 1989-07-19
JPH0520414B2 (de) 1993-03-19
ES2045141T3 (es) 1994-01-16
US5391550A (en) 1995-02-21
DK726088A (da) 1989-06-30
GR900300016T1 (en) 1991-06-07
DK726088D0 (da) 1988-12-28
CA1325593C (en) 1993-12-28
US4871718A (en) 1989-10-03
EP0324227B1 (de) 1992-06-24
AU1769088A (en) 1989-06-29
DE3872372D1 (de) 1992-07-30
DE324227T1 (de) 1989-11-16
NZ225106A (en) 1990-10-26
DE3872372T2 (de) 1992-12-10
AU600139B2 (en) 1990-08-02

Similar Documents

Publication Publication Date Title
DE3872372D1 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
IT1062219B (it) Glucopiranosido..i..6..mannite..procedimento per la sua preparazione e l'impiego della stessa come surrogato dello zucchero
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
HK17880A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
IE44034L (en) Pyrrolidone carboxylic acids.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
ATE4023T1 (de) Biflavanon enthaltende arzneimittel.
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee